These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2159561)

  • 1. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
    Tosato G; Tanner J; Jones KD; Revel M; Pike SE
    J Virol; 1990 Jun; 64(6):3033-41. PubMed ID: 2159561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
    Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
    Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lactic acid in autocrine B-cell growth stimulation.
    Pike SE; Markey SP; Ijames C; Jones KD; Tosato G
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11081-5. PubMed ID: 1662382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
    Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-transformed B lymphocytes produce low molecular mass molecules with autocrine growth factor and competence factor activity.
    Garzelli C; Bazzichi A; Dayah AM; Manunta M; Incaprera M; Falcone G
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):449-54. PubMed ID: 1335948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
    Tanner JE; Alfieri C
    Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line.
    Vandenabeele P; Jayaram B; Devos R; Shaw A; Fiers W
    Eur J Immunol; 1988 Jul; 18(7):1027-31. PubMed ID: 2841138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.
    Wakasugi H; Rimsky L; Mahe Y; Kamel AM; Fradelizi D; Tursz T; Bertoglio J
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):804-8. PubMed ID: 3027706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanism of T cell regulation of Epstein-Barr virus latency.
    Frugoni P; Pike SE; Tosato G
    Cell Immunol; 1993 Apr; 147(2):256-66. PubMed ID: 8095857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells.
    Cherney BW; Bhatia K; Tosato G
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12967-71. PubMed ID: 7809156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine growth of human B lymphocytes: maintained response to autostimulatory factors is the special feature of immortalization by Epstein-Barr virus--a hypothesis.
    Gordon J; Guy G; Walker L; Nathan P; Exley R; Clemens M
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):269-73. PubMed ID: 3027466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
    Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
    Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
    Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
    J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
    Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines.
    Jochems GJ; Klein MR; Jordens R; Pascual-Salcedo D; van Boxtel-Oosterhof F; van Lier RA; Zeijlemaker WP
    Hum Antibodies Hybridomas; 1991 Apr; 2(2):57-64. PubMed ID: 1651786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cells.
    Bende RJ; Jochems GJ; Frame TH; Klein MR; van Eijk RV; van Lier RA; Zeijlemaker WP
    Cell Immunol; 1992 Sep; 143(2):310-23. PubMed ID: 1324802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes.
    Baumann MA; Paul CC
    Blood; 1992 Apr; 79(7):1763-7. PubMed ID: 1313713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
    Lau YL; Shields JG; Levinsky RJ; Callard RE
    Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.